INVO Fertility (IVF) Gross Profit Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15.31% |
| Jun 30, 2025 | 27.91% |
| Mar 31, 2025 | 20.97% |
| Dec 31, 2024 | 17.39% |
| Sep 30, 2024 | 11.45% |
| Jun 30, 2024 | 10.07% |
| Mar 31, 2024 | 32.40% |
| Dec 31, 2023 | 34.82% |
| Sep 30, 2023 | 29.14% |
| Jun 30, 2023 | -3.03% |
| Mar 31, 2023 | 25.15% |
| Dec 31, 2022 | 23.14% |
| Sep 30, 2022 | 17.90% |
| Jun 30, 2022 | 0.52% |
| Mar 31, 2022 | 20.52% |
| Dec 31, 2021 | 241.89% |
| Sep 30, 2021 | 77.14% |
| Jun 30, 2021 | 129.22% |
| Mar 31, 2021 | 110.79% |
| Dec 31, 2020 | 158.10% |
| Sep 30, 2020 | 177.50% |
| Jun 30, 2020 | 106.31% |
| Mar 31, 2020 | 176.40% |
| Dec 31, 2019 | 192.78% |
| Sep 30, 2019 | 146.29% |
| Jun 30, 2019 | 329.46% |
| Mar 31, 2019 | 90.86% |
| Dec 31, 2018 | 63.63% |
| Sep 30, 2018 | 169.87% |
| Jun 30, 2018 | 116.83% |
| Mar 31, 2018 | 72.75% |
| Dec 31, 2017 | 34.80% |
| Sep 30, 2017 | 102.32% |
| Jun 30, 2017 | 53.91% |
| Mar 31, 2017 | 29.81% |
| Dec 31, 2016 | 30.23% |
| Sep 30, 2016 | 3.41% |
| Jun 30, 2016 | -27.62% |